Humasis Co

Humasis Co Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Humasis Co (205470.KQ) as of Nov 10, 2026 is 68.28. In the previous year, Days Inventory Outstanding (DIO) was 133.05 — a change of -48.68% (lower).

Days Inventory Outstanding

68.28

YoY

-48.68%

Last updated:

Days Inventory Outstanding (DIO) of Humasis Co is 2025 68.28 . Days Inventory Outstanding (DIO) of Humasis Co was 2024 133.05 . It decreases by -48.68% lower compared to the previous year.

The Humasis Co Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2018
164.57 KRW
Jan 1, 2019
205.09 KRW
Jan 1, 2020
257.87 KRW
Jan 1, 2021
169.97 KRW
Jan 1, 2022
72.02 KRW
Jan 1, 2023
58.66 KRW
Jan 1, 2024
133.05 KRW
Jan 1, 2025
68.28 KRW
The Humasis Co Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
68.28-48.68%
133.05+126.83%
58.66-18.56%
72.02-57.62%
169.97-34.09%
257.87+25.73%
205.09+24.62%
164.57-15.38%
194.47—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Humasis Co Stock analysis

What does Humasis Co do? Humasis Co., Ltd. develops rapid test kits and point-of-care testing instruments for the domestic and overseas markets. The company manufactures immunoquantitative analysis devices, myocardial infarction test equipment, infectious disease detection devices, hormone test devices, and cancer marker test devices. It also researches and develops biomaterials. Humasis sells its products to customers in South Korea and international markets, focusing on healthcare providers and medical institutions that require diagnostic tools for diseases like heart attacks, infections, and cancer. The company's revenue comes from the sale of its diagnostic devices and biomaterials research. Products include immunoquantitative analysis devices, myocardial infarction test equipment, and cancer marker test devices. These are sold to healthcare providers and medical institutions in South Korea and overseas. Humasis targets segments in the medical diagnostics field, particularly for cardiovascular, infectious disease, and oncology applications. Humasis Co., Ltd. operates in the medical device sector, focusing on point-of-care testing solutions. Its product portfolio includes devices for myocardial infarction, infectious diseases, hormones, and cancer markers. The company's sales are driven by demand from hospitals and clinics that need rapid diagnostic tools for patient care. The firm's research and development in biomaterials supports its product offerings in the medical diagnostics market. Humasis Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humasis Co stock

Days Inventory Outstanding (DIO) of Humasis Co is 68.28 in 2025.

Days Inventory Outstanding (DIO) of Humasis Co changed from 133.05 to 68.28, representing a -48.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Humasis Co since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Humasis Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Humasis Co

All Key Metrics — Humasis Co